Page last updated: 2024-08-23

atomoxetine hydrochloride and fluorodeoxyglucose f18

atomoxetine hydrochloride has been researched along with fluorodeoxyglucose f18 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
An, YS; Kim, YW; Shin, JC1
Constantinescu, CC; Mirbolooki, MR; Mukherjee, J; Pan, ML1

Other Studies

2 other study(ies) available for atomoxetine hydrochloride and fluorodeoxyglucose f18

ArticleYear
Treatment of chronic akinetic mutism with atomoxetine: subtraction analysis of brain f-18 fluorodeoxyglucose positron emission tomographic images before and after medication: a case report.
    Clinical neuropharmacology, 2010, Volume: 33, Issue:4

    Topics: Akinetic Mutism; Aneurysm, Ruptured; Atomoxetine Hydrochloride; Cognition; Fluorodeoxyglucose F18; Frontal Lobe; Glucose; Humans; Male; Middle Aged; Norepinephrine Plasma Membrane Transport Proteins; Occipital Lobe; Positron-Emission Tomography; Propylamines; Subarachnoid Hemorrhage; Subtraction Technique; Time Factors

2010
Targeting presynaptic norepinephrine transporter in brown adipose tissue: a novel imaging approach and potential treatment for diabetes and obesity.
    Synapse (New York, N.Y.), 2013, Volume: 67, Issue:2

    Topics: Adipose Tissue, Brown; Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Blood Glucose; Diabetes Mellitus, Type 2; Fluorodeoxyglucose F18; Male; Norepinephrine Plasma Membrane Transport Proteins; Obesity; Propranolol; Propylamines; Radionuclide Imaging; Rats; Rats, Sprague-Dawley

2013